COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
Autoři | |
---|---|
Rok publikování | 2022 |
Druh | Článek v odborném periodiku |
Časopis / Zdroj | Blood |
Fakulta / Pracoviště MU | |
Citace | |
www | https://ashpublications.org/blood/article/139/10/1588/477881/COVID-19-in-vaccinated-adult-patients-with |
Doi | http://dx.doi.org/10.1182/blood.2021014124 |
Klíčová slova | COVID-19; patients with hematological malignancies; vaccination; EPICOVIDEHA |
Popis | Coronavirus disease 2019 (COVID-19) is a life-threatening condition of high relevance for comorbid patients, such as those with baseline hematological malignancies (HM). In April 2020, the European Hematology Association - Infectious Diseases Working Party opened an open web-based registry to collect all cases of HM adult patients that developed COVID-19 infections (EPICOVIDEHA survey). This registry aimed to describe the epidemiology, risk factors, and mortality rates of HM patients. Overall, we collected 3801 valid cases, and we observed an overall mortality rate of 31%. |